Related Experiment Video
Updated: Aug 11, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
State of the science: neonatal bacterial infection in the early 21st century
1Louise Herrington School of Nursing, Baylor University, Dallas, Tex, USA. Judy_Lott@baylor.edu
Insights
Neonatal bacterial infections pose risks, especially for preterm infants. Early detection and treatment, alongside novel therapies, are crucial for improving outcomes in neonatal intensive care units.
Area of Science:
- Neonatology
- Infectious Diseases
- Pediatrics
Background:
- Bacterial infections are a major cause of illness and death in newborns, particularly premature infants in NICUs.
- Identifying maternal and infant risk factors aids in preventing infections and guiding early interventions.
Purpose of the Study:
- To provide an overview of current diagnostic and treatment strategies for neonatal infections.
- To highlight challenges in treating infections in vulnerable preterm neonates.
Main Methods:
- Review of clinical patterns for early- and late-onset neonatal infections.
- Discussion of diagnostic assessments and antimicrobial therapies.
- Exploration of emerging research in diagnostic markers and immunotherapies.
Main Results:
- Early recognition of distinct infection patterns is vital for optimal outcomes.
- Antibiotic resistance and immature immune systems complicate treatment.
- Ongoing research focuses on rapid diagnostics and immune support.
Conclusions:
- Effective management of neonatal infections requires prompt diagnosis and tailored treatment.
- Advancements in diagnostics and therapies are essential for improving survival and reducing morbidity in neonates.
Abstract:
Bacterial infections continue to cause significant neonatal morbidity and mortality, especially in small preterm neonates in the neonatal intensive care unit. Maternal and newborn risk factors can be used to prevent newborn infection and initiate early clinical assessments, laboratory diagnostic tests, and antimicrobial agent therapies. Early-onset and late-onset infections have different clinical patterns; however, each must be recognized as soon as possible in order to optimize outcomes. Antibiotics have long been the mainstay of treatment but organism resistance and weak immune system functioning of very premature newborns makes treatment challenging. Research continues on other markers for infection that may lead to more rapid diagnosis. The discovery of new therapies to improve newborn immune system function promises further improvement in outcomes of newborn infection. This article gives an overview of the state of diagnosis and treatment of newborn infection.
Related Concept Videos
Development of the Oral Microbiota
Development of Human Microbiota
Bacterial Meningitis I: Introduction
Clinical Significance of Antibiotic Resistance
Bacterial Meningitis II: Pathophysiology
History of Microbiology
